Atezolizumab + Cabozantinib Postpones mCRPC Progression.

Published Date: 29 Jan 2024

Comparing combination to more hormonal therapy, PFS was improved, but the control arm was questioned.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care

2.

PSMA PET Beats MRI in Prostate Cancer Staging Study

3.

Study finds 1 in 12 patients labeled as having 'benign' results actually had high-risk prostate cancer

4.

New imaging technique identifies glioblastoma patients who would benefit from immunotherapy

5.

The FDA Approves the New Frontline Aggressive ALL Regimen.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot